UK researchers are preparing trials to see if giving individuals 2 different kinds of Covid vaccine, one after the other, may offer better protection than two doses of one jab.
This mix-and-match method can go ahead just if another jab is approved by regulators, as has actually currently happened with the Pfizer/BioNTech vaccine.
The head of the UK’s vaccine job force stated trial designs were being prepared.
The news comes as the NHS starts its Covid mass vaccination programme.
A 90-year-old woman, Margaret Keenan, has actually become the first person to be given the Pfizer/BioNTech vaccine as part of the rollout throughout the UK.
Ms Keenan, who is originally from Enniskillen, said: “I feel so fortunate to be the first person vaccinated versus Covid-19. It’s the very best early birthday present I might wish for since it indicates I can finally look forward to hanging out with my friends and family in the new year after being on my own for most of the year.”
Strong immune reaction
That vaccine, provided as two dosages a couple of weeks apart, provides to 95% protection against Covid-19 health problem, according to information.
Although that is a very outstanding figure, specialists wish to check out whether the immune reaction can be enhanced further and made more durable with a mix-and-match “heterologous boost” technique.
Kate Bingham, who chairs the vaccine job force, stated: “It’s an established procedure.
” It’s not being done since of products.”
There is another Covid jab that might soon be authorized by regulators – the Oxford/AstraZeneca vaccine.
This operates in a somewhat various way to the Pfizer jab which might make it an excellent buddy for pairing, state researchers.
The Pfizer vaccine utilizes a percentage of hereditary code from the pandemic infection to teach the body how to fight off an infection, while the Oxford one is a genetically modified virus that has actually been altered so it won’t trigger infection but does bring information on how to beat Covid.
The idea is to provide individuals a shot of the Pfizer vaccine followed by a dosage of the Oxford one a couple of weeks later on or the other way around, instead of two doses of the very same vaccine.
The hope is that it will make the immune system produce 2 actions highly – antibodies and T-cells – to combat Covid.